Market Access News | pharmaphorum

News

Less than a week into the tenure of Robert F Kennedy Jr as HHS secretary, there are more signals that US immunisation is going to be shaken up.

News

Around 600 people with various types of B-cell lymphoma will be eligible for treatment with BMS' CAR-T therapy Breyanzi under new NICE guidance.

News

Boehringer Ingelheim's oral HER2 inhibitor zongertinib has started an FDA review as a lung cancer treatment with a decision due in the third quarter.

News

Around 1,400 patients with Lennox-Gastaut Syndrome will be eligible for NHS treatment with UCB's Fintepla after a NICE recommendation.

News

Gilead's already dominant position in HIV PrEP could be extended if the FDA approves a new twice-yearly injectable product later this year.

News

In his maiden speech as HHS Secretary, RFK Jr said he will investigate the role of childhood vaccines and other 'taboo' topics in chronic disease.